Back

Latest Forum Topics / Alset    Last:0.02 --

Post Reply

Singapore-eDev Post Reply Rate topic
guards80 Supreme	06-May-2020 09:54        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	No sl liaoz bought 100lot only 47. 51 200lot not much Starwar88      ( Date: 06-May-2020 09:53) Posted: Lol. Thought u SL at 47? But u bought more instead. Good to see if have a lot of confidence in this counter. Huat to all holders. guards80      ( Date: 06-May-2020 09:49) Posted: Bought some 47 for long term. Huat ah
Useful To Me  Not Useful To Me
Starwar88 Supreme	06-May-2020 09:53        Starwar88 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Lol. Thought u SL at 47? But u bought more instead. Good to see if have a lot of confidence in this counter. Huat to all holders. guards80      ( Date: 06-May-2020 09:49) Posted: Bought some 47 for long term. Huat ah
Useful To Me  Not Useful To Me
noobnub Supreme	06-May-2020 09:52        noobnub About Contact  Quote this Post!
x 0   x 0  Alert Admin	made 3 bids today. no pt saying since mostly long here. later the usual will have people say influence panic etc.
Useful To Me  Not Useful To Me
guards80 Supreme	06-May-2020 09:49        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Bought some 47 for long term. Huat ah
Useful To Me  Not Useful To Me
noobnub Supreme	06-May-2020 09:47        noobnub About Contact  Quote this Post!
x 0   x 0  Alert Admin	good luck. this is no hindsight noobnub      ( Date: 05-May-2020 11:28) Posted: when its apparent it may be trading between 47-49 noobnub      ( Date: 04-May-2020 16:55) Posted: ususally wont be so apparant until its too late. hah
Useful To Me  Not Useful To Me
dimebag Master	06-May-2020 09:44        dimebag About Contact  Quote this Post!
x 0   x 0  Alert Admin	I'm not vested just commenting oreocookie      ( Date: 06-May-2020 01:56) Posted: then you better sell bro dimebag      ( Date: 06-May-2020 01:16) Posted: DSS down more than 8% now, think SED gone case for the short term already.
Useful To Me  Not Useful To Me
oreocookie Senior	06-May-2020 01:56        oreocookie About Contact  Quote this Post!
x 0   x 0  Alert Admin	then you better sell bro dimebag      ( Date: 06-May-2020 01:16) Posted: DSS down more than 8% now, think SED gone case for the short term already.
Useful To Me  Not Useful To Me
dimebag Master	06-May-2020 01:16        dimebag About Contact  Quote this Post!
x 0   x 0  Alert Admin	DSS down more than 8% now, think SED gone case for the short term already.
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 23:57        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Impact BioMedical' s Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak http://en.antaranews.com/news/144490/impact-biomedicals-linebacker-and-equivir-inhibit-sars-cov-2-virus-responsible-for-the-covid-19-outbreak
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 19:20        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	old news bro. march one. but look good further studies to test Equivir as a potential treatment of COVID-19, the disease caused by the pandemic novel coronavirus SARS-CoV2. happietrade      ( Date: 05-May-2020 19:13) Posted: When was this news? guards80      ( Date: 05-May-2020 19:04) Posted: DSS: Plans to Invest in Two New Ventures: Impact Biomedical and a Medical REIT Impact Biomedical On Friday, Document Security Systems, Inc.&rsquo s (NYSE:DSS) stock popped when it announced that it has entered into a binding term sheet to acquire Impact Biomedical, Inc. Impact has a number of healthcare products in development. The stock rose because in the company&rsquo s press release it highlighted Impact&rsquo s product called Equivir, which has been shown in studies to be effective as an antiviral against a broad range of viruses including in vitro efficacy against multiple strains of Influenza (H1N1, H3N2, H5N1, H7N9, Influenza B, Parainfluenza 3), Human Rhinovirus-14, Human Coronavirus-A, and Ebola. Equivir&rsquo s abilities to inhibit viruses via multiple targets have prompted further studies to test Equivir as a potential treatment of COVID-19, the disease caused by the pandemic novel coronavirus SARS-CoV2. Impact Biomedical is a wholly owned subsidiary of Global Biomedical Pte Ltd and Singapore eDevelopment Limited, a public company listed in Singapore (SGX-ST)(StockCode: 40V). Singapore eDevelopment is an investment holding company, engaged in the property development, information technology (IT), biomedical, and investment businesses in Singapore, Australia, the United States, and the People' s Republic of China. It was incorporated in 2009, based in Singapore, and is a subsidiary of Hengfai Business Development Pte. Ltd. Its chairman is executive chairman and CEO is Heng Fai Chan who is also Chairman of DSS and its major shareholder. DSS plans a share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and independent valuation. Impact is expected to be valued far in excess of that $50 million purchase price but will need significant funds to reach marketability of any of its potential products. DSS management believes that it can fund development costs through partnerships and an IPO of Impact. To acquire Impact, DSS will issue up to 14.5 M shares of stock and a perpetual convertible preferred. The preferred stock will be convertible at $0.216 per share and have a 19.9% blocker. The proposed bonus being, for every one DSS share held, the shareholder will be entitled to a bonus of two Impact shares. After acquisition, DSS will be the majority shareholder and management plans to pursue an IPO of Impact, at which point part of the company will be spun off to DSS shareholders.
Useful To Me  Not Useful To Me
happietrade Master	05-May-2020 19:13        happietrade About Contact  Quote this Post!   Yells: "be kind"
x 0   x 0  Alert Admin	When was this news? guards80      ( Date: 05-May-2020 19:04) Posted: DSS: Plans to Invest in Two New Ventures: Impact Biomedical and a Medical REIT Impact Biomedical On Friday, Document Security Systems, Inc.&rsquo s (NYSE:DSS) stock popped when it announced that it has entered into a binding term sheet to acquire Impact Biomedical, Inc. Impact has a number of healthcare products in development. The stock rose because in the company&rsquo s press release it highlighted Impact&rsquo s product called Equivir, which has been shown in studies to be effective as an antiviral against a broad range of viruses including in vitro efficacy against multiple strains of Influenza (H1N1, H3N2, H5N1, H7N9, Influenza B, Parainfluenza 3), Human Rhinovirus-14, Human Coronavirus-A, and Ebola. Equivir&rsquo s abilities to inhibit viruses via multiple targets have prompted further studies to test Equivir as a potential treatment of COVID-19, the disease caused by the pandemic novel coronavirus SARS-CoV2. Impact Biomedical is a wholly owned subsidiary of Global Biomedical Pte Ltd and Singapore eDevelopment Limited, a public company listed in Singapore (SGX-ST)(StockCode: 40V). Singapore eDevelopment is an investment holding company, engaged in the property development, information technology (IT), biomedical, and investment businesses in Singapore, Australia, the United States, and the People' s Republic of China. It was incorporated in 2009, based in Singapore, and is a subsidiary of Hengfai Business Development Pte. Ltd. Its chairman is executive chairman and CEO is Heng Fai Chan who is also Chairman of DSS and its major shareholder. DSS plans a share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and independent valuation. Impact is expected to be valued far in excess of that $50 million purchase price but will need significant funds to reach marketability of any of its potential products. DSS management believes that it can fund development costs through partnerships and an IPO of Impact. To acquire Impact, DSS will issue up to 14.5 M shares of stock and a perpetual convertible preferred. The preferred stock will be convertible at $0.216 per share and have a 19.9% blocker. The proposed bonus being, for every one DSS share held, the shareholder will be entitled to a bonus of two Impact shares. After acquisition, DSS will be the majority shareholder and management plans to pursue an IPO of Impact, at which point part of the company will be spun off to DSS shareholders.
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 19:04        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	DSS: Plans to Invest in Two New Ventures: Impact Biomedical and a Medical REIT Impact Biomedical On Friday, Document Security Systems, Inc.&rsquo s (NYSE:DSS) stock popped when it announced that it has entered into a binding term sheet to acquire Impact Biomedical, Inc. Impact has a number of healthcare products in development. The stock rose because in the company&rsquo s press release it highlighted Impact&rsquo s product called Equivir, which has been shown in studies to be effective as an antiviral against a broad range of viruses including in vitro efficacy against multiple strains of Influenza (H1N1, H3N2, H5N1, H7N9, Influenza B, Parainfluenza 3), Human Rhinovirus-14, Human Coronavirus-A, and Ebola. Equivir&rsquo s abilities to inhibit viruses via multiple targets have prompted further studies to test Equivir as a potential treatment of COVID-19, the disease caused by the pandemic novel coronavirus SARS-CoV2. Impact Biomedical is a wholly owned subsidiary of Global Biomedical Pte Ltd and Singapore eDevelopment Limited, a public company listed in Singapore (SGX-ST)(StockCode: 40V). Singapore eDevelopment is an investment holding company, engaged in the property development, information technology (IT), biomedical, and investment businesses in Singapore, Australia, the United States, and the People' s Republic of China. It was incorporated in 2009, based in Singapore, and is a subsidiary of Hengfai Business Development Pte. Ltd. Its chairman is executive chairman and CEO is Heng Fai Chan who is also Chairman of DSS and its major shareholder. DSS plans a share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and independent valuation. Impact is expected to be valued far in excess of that $50 million purchase price but will need significant funds to reach marketability of any of its potential products. DSS management believes that it can fund development costs through partnerships and an IPO of Impact. To acquire Impact, DSS will issue up to 14.5 M shares of stock and a perpetual convertible preferred. The preferred stock will be convertible at $0.216 per share and have a 19.9% blocker. The proposed bonus being, for every one DSS share held, the shareholder will be entitled to a bonus of two Impact shares. After acquisition, DSS will be the majority shareholder and management plans to pursue an IPO of Impact, at which point part of the company will be spun off to DSS shareholders.
Useful To Me  Not Useful To Me
happietrade Master	05-May-2020 19:00        happietrade About Contact  Quote this Post!   Yells: "be kind"
x 0   x 0  Alert Admin	Noted thanks Ryueenji and SgYuan
Useful To Me  Not Useful To Me
SgYuan Supreme	05-May-2020 18:59        SgYuan About Contact  Quote this Post!
x 0   x 0  Alert Admin	ok thks Ryuuenji      ( Date: 05-May-2020 18:55) Posted: Be cautious.. !
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 18:58        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	if price go down to 45 i want to buy some more hold for long term.... guards80      ( Date: 05-May-2020 18:57) Posted: since DSS Acquisition of Impact Biomedical. should be very good news. price should trade above 100.
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 18:57        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	since DSS Acquisition of Impact Biomedical. should be very good news. price should trade above 100.
Useful To Me  Not Useful To Me
Ryuuenji Elite	05-May-2020 18:55        Ryuuenji About Contact  Quote this Post!
x 0   x 0  Alert Admin	Be cautious.. !
Useful To Me  Not Useful To Me
happietrade Master	05-May-2020 18:44        happietrade About Contact  Quote this Post!   Yells: "be kind"
x 0   x 0  Alert Admin	Thank you!! SgYuan      ( Date: 05-May-2020 18:36) Posted: Yap still valid ew 41 47 45 57 ? w1 6 w2 2 w3 12 up 200% w4 5 tgt 52 dn 38.2% - now px hit 50 delta 7 dn 58.3% over corrected - also the mini ew reset 50 55 50 reset - this must be supported then w5 come w5 11 tgt 61 up 61.8% of 18 If px break 50, looking at next level ew ew 41 57 w2? w1 16 w2 10 tgt 47 dn 61.8% - px 47 must be supported then  - next w3 ext ew can come (another 5 wave) 30min chart ew happietrade      ( Date: 05-May-2020 18:11) Posted: Master yuan this chart still stands right
Useful To Me  Not Useful To Me
SgYuan Supreme	05-May-2020 18:36        SgYuan About Contact  Quote this Post!
x 0   x 0  Alert Admin	Yap still valid ew 41 47 45 57 ? w1 6 w2 2 w3 12 up 200% w4 5 tgt 52 dn 38.2% - now px hit 50 delta 7 dn 58.3% over corrected - also the mini ew reset 50 55 50 reset - this must be supported then w5 come w5 11 tgt 61 up 61.8% of 18 If px break 50, looking at next level ew ew 41 57 w2? w1 16 w2 10 tgt 47 dn 61.8% - px 47 must be supported then  - next w3 ext ew can come (another 5 wave) 30min chart ew happietrade      ( Date: 05-May-2020 18:11) Posted: Master yuan this chart still stands right? SgYuan      ( Date: 05-May-2020 11:35) Posted: 15m chart ew ew 50 55 w2?51 w1 5 w2 3 tgt 52 px hit 51 - px cannot break 50 w3 8 tgt 59 w4 3 tgt 56 w5 5 tgt 61
Useful To Me  Not Useful To Me
guards80 Supreme	05-May-2020 18:32        guards80 About Contact  Quote this Post!
x 0   x 0  Alert Admin	oic huat ah. i bought at 51. once 50 support well then w3 59 coming. happietrade      ( Date: 05-May-2020 18:28) Posted: Yeah I bought small small at 52 this morning
Useful To Me  Not Useful To Me

                                                         First   < Newer   7381-7400 of 8048   Older>   Last